Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method

Lisa Bleyle, Hidde H. Huidekoper, Frederic M. Vaz, Renu Singh, Robert D. Steiner, Andrea De Barber

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid synthesis that can cause progressive neurological damage and premature death. Detection of CTX in the newborn period would be beneficial since an effective treatment is available. We previously described a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) test with potential to screen newborn dried bloodspots (DBS) for CTX. We report here modifications to the methodology and application of the modified test to analysis of DBS from a CTX-affected and unaffected newborns. Methods The testing methodology utilizes keto derivatization to enable sensitive LC-ESI-MS/MS measurement of elevated 7α,12α-dihydroxy-4-cholesten-3-one (7α12αC4) in CTX newborn DBS. We report here method modifications, including use of a DBS extraction procedure used in newborn screening laboratories and a reduced analysis time of 2 min per sample. Results Rapid isotope-dilution LC-ESI/MS/MS quantification of the ketosterol bile acid precursor 7α12αC4 provides a test that could readily discriminate a CTX positive newborn DBS sample (with a concentration of 104.4 ng/ml) from unaffected newborn samples (with a mean concentration of 4.1 ± 3.4 ng/ml; range 0.2-15.6 ng/ml, n = 39) analyzed in a blinded manner. Conclusions We provide additional evidence suggesting 7α12αC4 may be a promising test marker to screen newborn DBS for CTX. Early detection and intervention through newborn screening would greatly benefit those affected with CTX, preventing morbidity and mortality.

Original languageEnglish (US)
Pages (from-to)11-15
Number of pages5
JournalMolecular Genetics and Metabolism Reports
Volume7
DOIs
StatePublished - Jun 1 2016

Fingerprint

Cerebrotendinous Xanthomatosis
Tandem Mass Spectrometry
Liquid Chromatography
Bile Acids and Salts
Inborn Genetic Diseases
Premature Mortality
Electrospray Ionization Mass Spectrometry
Isotopes
Morbidity

Keywords

  • 7α12αC4 7α,12α-dihydroxy-4-cholesten-3-one
  • Abbreviations CTX cerebrotendinous xanthomatosis
  • CDCA chenodeoxycholic acid
  • DBS dried bloodspots
  • ESI-MS/MS liquid chromatography-electrospray ionization-tandem MS
  • GC-MS gas chromatography-mass spectrometry
  • IRB institutional Review Board
  • LLOQ lower limit of quantification
  • MRM multiple reaction monitoring
  • QAO quaternary amonoxy
  • QCs quality control samples
  • RSD relative standard deviation
  • S/N signal-to-noise

ASJC Scopus subject areas

  • Endocrinology
  • Genetics
  • Molecular Biology

Cite this

Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis : An available high-throughput liquid-chromatography tandem mass spectrometry method. / Bleyle, Lisa; Huidekoper, Hidde H.; Vaz, Frederic M.; Singh, Renu; Steiner, Robert D.; De Barber, Andrea.

In: Molecular Genetics and Metabolism Reports, Vol. 7, 01.06.2016, p. 11-15.

Research output: Contribution to journalArticle

Bleyle, Lisa ; Huidekoper, Hidde H. ; Vaz, Frederic M. ; Singh, Renu ; Steiner, Robert D. ; De Barber, Andrea. / Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis : An available high-throughput liquid-chromatography tandem mass spectrometry method. In: Molecular Genetics and Metabolism Reports. 2016 ; Vol. 7. pp. 11-15.
@article{28110cbbb03a42bc8444391d9044cb48,
title = "Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis: An available high-throughput liquid-chromatography tandem mass spectrometry method",
abstract = "Background Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid synthesis that can cause progressive neurological damage and premature death. Detection of CTX in the newborn period would be beneficial since an effective treatment is available. We previously described a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) test with potential to screen newborn dried bloodspots (DBS) for CTX. We report here modifications to the methodology and application of the modified test to analysis of DBS from a CTX-affected and unaffected newborns. Methods The testing methodology utilizes keto derivatization to enable sensitive LC-ESI-MS/MS measurement of elevated 7α,12α-dihydroxy-4-cholesten-3-one (7α12αC4) in CTX newborn DBS. We report here method modifications, including use of a DBS extraction procedure used in newborn screening laboratories and a reduced analysis time of 2 min per sample. Results Rapid isotope-dilution LC-ESI/MS/MS quantification of the ketosterol bile acid precursor 7α12αC4 provides a test that could readily discriminate a CTX positive newborn DBS sample (with a concentration of 104.4 ng/ml) from unaffected newborn samples (with a mean concentration of 4.1 ± 3.4 ng/ml; range 0.2-15.6 ng/ml, n = 39) analyzed in a blinded manner. Conclusions We provide additional evidence suggesting 7α12αC4 may be a promising test marker to screen newborn DBS for CTX. Early detection and intervention through newborn screening would greatly benefit those affected with CTX, preventing morbidity and mortality.",
keywords = "7α12αC4 7α,12α-dihydroxy-4-cholesten-3-one, Abbreviations CTX cerebrotendinous xanthomatosis, CDCA chenodeoxycholic acid, DBS dried bloodspots, ESI-MS/MS liquid chromatography-electrospray ionization-tandem MS, GC-MS gas chromatography-mass spectrometry, IRB institutional Review Board, LLOQ lower limit of quantification, MRM multiple reaction monitoring, QAO quaternary amonoxy, QCs quality control samples, RSD relative standard deviation, S/N signal-to-noise",
author = "Lisa Bleyle and Huidekoper, {Hidde H.} and Vaz, {Frederic M.} and Renu Singh and Steiner, {Robert D.} and {De Barber}, Andrea",
year = "2016",
month = "6",
day = "1",
doi = "10.1016/j.ymgmr.2016.02.002",
language = "English (US)",
volume = "7",
pages = "11--15",
journal = "Molecular Genetics and Metabolism Reports",
issn = "2214-4269",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Update on newborn dried bloodspot testing for cerebrotendinous xanthomatosis

T2 - An available high-throughput liquid-chromatography tandem mass spectrometry method

AU - Bleyle, Lisa

AU - Huidekoper, Hidde H.

AU - Vaz, Frederic M.

AU - Singh, Renu

AU - Steiner, Robert D.

AU - De Barber, Andrea

PY - 2016/6/1

Y1 - 2016/6/1

N2 - Background Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid synthesis that can cause progressive neurological damage and premature death. Detection of CTX in the newborn period would be beneficial since an effective treatment is available. We previously described a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) test with potential to screen newborn dried bloodspots (DBS) for CTX. We report here modifications to the methodology and application of the modified test to analysis of DBS from a CTX-affected and unaffected newborns. Methods The testing methodology utilizes keto derivatization to enable sensitive LC-ESI-MS/MS measurement of elevated 7α,12α-dihydroxy-4-cholesten-3-one (7α12αC4) in CTX newborn DBS. We report here method modifications, including use of a DBS extraction procedure used in newborn screening laboratories and a reduced analysis time of 2 min per sample. Results Rapid isotope-dilution LC-ESI/MS/MS quantification of the ketosterol bile acid precursor 7α12αC4 provides a test that could readily discriminate a CTX positive newborn DBS sample (with a concentration of 104.4 ng/ml) from unaffected newborn samples (with a mean concentration of 4.1 ± 3.4 ng/ml; range 0.2-15.6 ng/ml, n = 39) analyzed in a blinded manner. Conclusions We provide additional evidence suggesting 7α12αC4 may be a promising test marker to screen newborn DBS for CTX. Early detection and intervention through newborn screening would greatly benefit those affected with CTX, preventing morbidity and mortality.

AB - Background Cerebrotendinous xanthomatosis (CTX) is a rare genetic disorder of bile acid synthesis that can cause progressive neurological damage and premature death. Detection of CTX in the newborn period would be beneficial since an effective treatment is available. We previously described a liquid chromatography-electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) test with potential to screen newborn dried bloodspots (DBS) for CTX. We report here modifications to the methodology and application of the modified test to analysis of DBS from a CTX-affected and unaffected newborns. Methods The testing methodology utilizes keto derivatization to enable sensitive LC-ESI-MS/MS measurement of elevated 7α,12α-dihydroxy-4-cholesten-3-one (7α12αC4) in CTX newborn DBS. We report here method modifications, including use of a DBS extraction procedure used in newborn screening laboratories and a reduced analysis time of 2 min per sample. Results Rapid isotope-dilution LC-ESI/MS/MS quantification of the ketosterol bile acid precursor 7α12αC4 provides a test that could readily discriminate a CTX positive newborn DBS sample (with a concentration of 104.4 ng/ml) from unaffected newborn samples (with a mean concentration of 4.1 ± 3.4 ng/ml; range 0.2-15.6 ng/ml, n = 39) analyzed in a blinded manner. Conclusions We provide additional evidence suggesting 7α12αC4 may be a promising test marker to screen newborn DBS for CTX. Early detection and intervention through newborn screening would greatly benefit those affected with CTX, preventing morbidity and mortality.

KW - 7α12αC4 7α,12α-dihydroxy-4-cholesten-3-one

KW - Abbreviations CTX cerebrotendinous xanthomatosis

KW - CDCA chenodeoxycholic acid

KW - DBS dried bloodspots

KW - ESI-MS/MS liquid chromatography-electrospray ionization-tandem MS

KW - GC-MS gas chromatography-mass spectrometry

KW - IRB institutional Review Board

KW - LLOQ lower limit of quantification

KW - MRM multiple reaction monitoring

KW - QAO quaternary amonoxy

KW - QCs quality control samples

KW - RSD relative standard deviation

KW - S/N signal-to-noise

UR - http://www.scopus.com/inward/record.url?scp=84960409966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960409966&partnerID=8YFLogxK

U2 - 10.1016/j.ymgmr.2016.02.002

DO - 10.1016/j.ymgmr.2016.02.002

M3 - Article

AN - SCOPUS:84960409966

VL - 7

SP - 11

EP - 15

JO - Molecular Genetics and Metabolism Reports

JF - Molecular Genetics and Metabolism Reports

SN - 2214-4269

ER -